stars 1 stars 2 stars 3

View Illumivein's top competitors like Acclarent, AccuVein Inc., and Bovie Medical Corporation.

Tactile Medical
Tactile Medical is one of the fastest growing companies in medical devices. As a leader in treatment options for lymphedema and venous ulcer therapies, Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.
Minneapolis, Minnesota, US
Public
$213.3M Revenue
https://www.tactilemedical.com/
775 Employees
TCMD Ticker
Lumenis
Lumenis creates and commercializes innovative energy-based technologies that enable a variety of skin, body, and eye care treatments. We have successfully introduced solutions for previously untreatable conditions and designed advanced technologies that have revolutionized existing treatment methods. We are BeautyTech pioneers, empowering people by broadening the horizons of health and celebrating beauty that matters. Lumenis has a rich history of defying technological boundaries, redefining standards within our domains, and transforming people’s lives - both inside and out. Our drive for innovation stems from an uncompromising commitment to providing best-in-class technologies and solutions designed to achieve excellent results. Lumenis has a solid global footprint in developed and emerging markets and sales in over 100 countries. Headquartered in Israel and with offices on four continents, our team consists of nearly 1,500 professionals worldwide.
San Jose, California, US
Public
$363M Revenue
http://www.lumenis.com
1.4K Employees
NASDAQ:LMNS Ticker
Acclarent
Acclarent, Inc., part of Integra LifeSciences, is a medical device company in Irvine, CA that was established in June of 2004. We’re dedicated to supporting Ear, Nose, and Throat (ENT) surgeons with minimally invasive technologies designed to preserve nasal anatomy, while addressing rhinosinusitis and persistent Eustachian Tube Dysfunction. Commercially launched in 2005, our Balloon Sinuplasty technology has been used by otolaryngologists in over 535,000 procedures. ©Acclarent, Inc. 2022
Irvine, California, US
Private
$9.2M Revenue
http://www.acclarent.com
169 Employees
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users